Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2006-02-07
2006-02-07
Saeed, Kamal A. (Department: 1626)
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
active
06995271
ABSTRACT:
The present invention relates to a novel method for producing a compound of the formula [11]wherein R is an optionally substituted aromatic hydrocarbon group, an optionally substituted alicyclic hydrocarbon group, an optionally substituted heterocyclic group or an optionally substituted condensed heterocyclic group, which is useful as a therapeutic agent for diabetes. The method of the present invention is an industrially utilizable method that enables efficient production of the objective compound [11] from β-methyl L-aspartate via an important intermediate compound [6]wherein R is as defined above, at high yield.
REFERENCES:
patent: 4602027 (1986-07-01), Meguro et al.
patent: 5059720 (1991-10-01), Hung
patent: 5728720 (1998-03-01), Shinkai
patent: 5753681 (1998-05-01), Fujiwara et al.
patent: 5763467 (1998-06-01), Goldstein et al.
patent: 5932601 (1999-08-01), Sohda et al.
patent: 6248897 (2001-06-01), Ando et al.
patent: 177 353 (1986-04-01), None
patent: 544 696 (1993-06-01), None
patent: 796618 (1997-09-01), None
patent: 58 219169 (1983-12-01), None
patent: 5 508654 (1993-12-01), None
patent: A-7-188227 (1995-07-01), None
patent: 95/18125 (1995-07-01), None
Meguro et al., Chem. Pharm. Bull., vol. 34, No. 7, “Studies on Antidiabetic Agents VII . . . Acid Derivatives”; pp. 2840-2851, 1986.
ABSTRACT: A. Rosowsky et al., “Side Chain modified . . . 8-dideazafolic acid”, J. Med. Chem., vol. 35:14, pp. 2626-2630, 1992.
ABSTRACT: H. Shinkai, “Isoxazolidine-3, 5-dione . . . Hypoglycemic Agents”, J. Med. Chem., vol. 41:11, pp. 1927-1933 (1998).
T. Sohda et al., “Studies on Antidiabetic Agents . . . Hypolipidemic Agents”, J. Med. Chem., vol. 35:14, pp. 2617-2626, 1992.
ABSTRACT: B. Hulin et al., J. Med. Chem., vol. 25, No. 10, Novel thiazolidine-2, 4-diones as potent euglycemic agents, pp. 1853-1864.
ABSTRACT: H. Shinkai, “The isoxazolidine-3, 5-dione . . . insulin sensitizers”, Drugs Future, vol. 24:8, pp. 893-898, 1999.
Accession No. 2001:416908, compounds RN 341986-88-7, RN 341987-21-1, RN 341987-67-5, and RN 341987-86-8; Accession No. 1979:6388, compounds RN 68430-56-8, RN 68430-64-8, and RN 68430-65-9, and Accession No. 1978:89653.
X. Qiyi, “Basic Organic Chemistry,” 2ndEdition, p. 603, Jun. 1994, The Higher Education Publisher of China, People's Republic of China, Abstract.
Ando Koji
Suzuki Masanobu
Foley & Lardner LLP
Japan Tobacco Inc.
Saeed Kamal A.
LandOfFree
Production method of isoxazolidinedione compound does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Production method of isoxazolidinedione compound, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Production method of isoxazolidinedione compound will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3649020